top of page

Aaron Haeusler Research

Identifying neurodegenerative

mechanisms and interventions for ALS and FTD

Neuron 2 no style 2 print.jpg

Research

We are motivated and driven to understand how molecular mechanisms drive disease in patients with ALS/FTD. Our primary research goal is to identify the molecular cascade of pathogenic events that are initiated in these debilitating diseases in efforts to develop efficacious therapeutic strategies.

Latest Publications

Intrathecal (G4C2)149 delivery in C9orf72-deficient mice yields mild motor dysfunction and ALS/FTD pathological hallmarks
Katelyn Russell et al. 2026. Acta Neuropahol Commun

A C9ORF72 repeat expansion is the leading genetic cause of ALS and FTD. We developed a mouse model combining widespread CNS expression of (G4C2)149 repeats, including robust spinal cord targeting, with varying levels of C9orf72loss. Mice exhibited progressive muscle weakness, subtle gait abnormalities, and spinal cord pathology, including dipeptide repeat protein accumulation, motor neuron loss, glial activation, and TDP-43 dysfunction. These findings establish a model that captures key features of ALS/FTD and enables investigation of how C9orf72 gain- and loss-of-function mechanisms contribute to disease.

Neuron 2 no style 2 print_edited.png

Contact us

email: AaronHaeusler at gmail dot com

Disclaimer: The views expressed on this website are my own and may not reflect the views shared by the Weinberg ALS Center, the Sidney Kimmel Medical College, the Vickie and Jack Farber Institute for Neuroscience, nor Thomas Jefferson University.

bottom of page